Adimmune to shift vaccine research to focus on new COVID-19 variants
Taipei, Feb. 17 (CNA) Taiwan's Adimmune Corp., which has fallen behind two other domestic pharmaceutical firms in the race to roll out a COVID-19 vaccine, said Wednesday that it will shift its focus to developing vaccines targeting new variants of the virus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Second man dies in Kaohsiung oil storage tank accident01/16/2022 06:35 PM
Taiwan sees 10 new domestic cases, including 1 disease control staff01/16/2022 05:37 PM
Magnitude 5.5 earthquake jolts eastern Taiwan01/16/2022 04:40 PM
Taiwan, Lithuania ties evolve in face of Chinese pressure01/16/2022 03:56 PM